| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 19.811 | 45.543 | 43.625 | 52.369 | 58.967 | 73.158 |
| Total Income - EUR | - | - | - | - | 19.811 | 47.610 | 43.625 | 52.370 | 58.968 | 73.159 |
| Total Expenses - EUR | - | - | - | - | 10.856 | 24.975 | 23.022 | 22.733 | 23.401 | 24.190 |
| Gross Profit/Loss - EUR | - | - | - | - | 8.955 | 22.636 | 20.603 | 29.636 | 35.567 | 48.970 |
| Net Profit/Loss - EUR | - | - | - | - | 8.757 | 22.190 | 20.167 | 29.191 | 34.989 | 46.815 |
| Employees | - | - | - | - | 3 | 3 | 3 | 3 | 2 | 2 |
Check the financial reports for the company - Nova Vision Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 580 | 265 | 0 | 0 | 0 | 729 |
| Current Assets | - | - | - | - | 11.575 | 34.418 | 51.343 | 80.819 | 36.383 | 49.030 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 5.000 | 26.383 | 43.464 |
| Cash | - | - | - | - | 11.575 | 34.418 | 51.343 | 75.819 | 10.000 | 5.566 |
| Shareholders Funds | - | - | - | - | 8.591 | 30.619 | 50.106 | 79.452 | 35.029 | 46.855 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.564 | 4.065 | 1.237 | 1.367 | 1.354 | 2.903 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Nova Vision Med S.r.l.